Advancements in cancer treatment have opened new doors for patients, providing more effective and tailored options. While traditional methods like surgery, chemotherapy, and radiation continue to play a crucial role, newer approaches are gaining ground. Targeted therapies focus on disrupting the specific molecular pathways that drive cancer growth, while immunotherapies harness the body’s immune system to better target cancer cells. Additionally, personalized medicine is revolutionizing treatment by customizing therapies based on the patient’s genetic makeup. Together, these innovations are transforming cancer care, offering greater hope for improved survival rates and quality of life.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Spatial multi-omics inference of diabetes-triggered pancreatic cancer growth: The key role of cholesterol-induced neutrophil extracellular
Guanqun Li, The First Affiliated Hospital of Harbin Medical University, China
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada